Lyt-200 is a fully human anti-Gal-9 IgG4 monoclonal ab that showed direct pro-apoptotic and DNA damage effects on AML tumor cells both in vitro and in vivo [226]. Here, LGALS9 is linked to acute myeloid leukemia.